✦ LIBER ✦

Liposomal doxorubicin appears to have activity in platinum-resistant ovarian cancer,

Book ID: 120869493
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2000
Weight: 133 KB
Volume: &NA;
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-200012570-00043

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Adverse event profile by folate receptor

Adverse event profile by folate receptor status for vintafolide+pegylated liposomal doxorubicin vs pegylated liposomal doxorubicin alone in platinum-resistant ovarian cancer

✍ Herzog, T.J.; Kutarska, E.; Bidzinski, M.; Symanowski, J.; Nguyen, B.; Rangwala, 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 98 KB

Pegylated liposomal doxorubicin with bev

Pegylated liposomal doxorubicin with bevacizumab in the treatment of platinum-resistant ovarian cancer: Toxicity profile results

✍ S. Czok; A. Jewell; S. Shawki; L. Boyd; H. Smith; S. Blank; C. Muller; C. Versch 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Phase 1/2 Study of Atrasentan Combined w

Phase 1/2 Study of Atrasentan Combined with Pegylated Liposomal Doxorubicin in Platinum-Resistant Recurrent Ovarian Cancer

✍ Witteveen, Petronella O.; van der Mijn, Koen J.C.; Los, Maartje; Kronemeijer, Ro 📂 Article 📅 2010 🏛 Neoplasia Press 🌐 English ⚖ 147 KB

Phase II study of the combination of peg

Phase II study of the combination of pegylated liposomal doxorubicin and topotecan in platinum-resistant ovarian cancer

✍ M. VERHAAR-LANGEREIS; A. KARAKUS; M. Van EIJKEREN; E. VOEST; E. WIT 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB

Phase II study of bevacizumab with lipos

Phase II study of bevacizumab with liposomal doxorubicin for patients with platinum- and taxane-resistant ovarian cancer

✍ Verschraegen, C. F.; Czok, S.; Muller, C. Y.; Boyd, L.; Lee, S. J.; Rutledge, T. 📂 Article 📅 2012 🏛 Oxford University Press 🌐 English ⚖ 144 KB

Randomized Phase III Trial of Gemcitabin

Randomized Phase III Trial of Gemcitabine Compared With Pegylated Liposomal Doxorubicin in Patients With Platinum-Resistant Ovarian Cancer

✍ Mutch, D. G.; Orlando, M.; Goss, T.; Teneriello, M. G.; Gordon, A. N.; McMeekin, 📂 Article 📅 2007 🏛 American Society of Clinical Oncology 🌐 English ⚖ 325 KB